News & Announcements
EndoRx and DFC Medical were honored to be the primary underwriting sponsors for this diverse and dynamic group of women in a runway show like no other – a runway of role models.
NovaScan, a clinical-stage oncology company based in Chicago, has announced the appointment of luminaries in interventional pulmonology and gastroenterology to lead initiatives in lung and GI, respectively.
NovaScan, a clinical-stage oncology company based in Chicago and Milwaukee, recently had its publication titled “The Cole Relaxation Frequency as a Parameter to Identify Cancer in Lung Tissue: Preliminary Animal and ex vivo Patient Studies” accepted in the highly regarded peer-reviewed journal, JMIR Biomedical Engineering.
NovaScan announced that it has completed a $8 Million Series B financing, led by Builders VC. As a part of this transaction, Amit Mehta, MD, a partner at Builders, will join the Board of Directors of NovaScan.